End-of-life care

New palliative care policy launched for people with serious respiratory illness

An ATS policy statement on palliative care for people with serious respiratory illness has reinforced the importance of introducing palliative care early in the care continuum. Presented at ATS 2022, the long awaited update of a 2008 statement also fleshes...

An ATS policy statement on palliative care for people with serious respiratory illness has reinforced the importance of introducing palliative...
Lung cancer

Unexplained delays in follow-up after positive findings in lung cancer screening

Almost half of patients with high risk findings at CT screening for lung cancer are not returning in a timely fashion for the recommended follow-up, according to US data presented at the ATS 2022 A retrospective cohort study from Washington state...

Almost half of patients with high risk findings at CT screening for lung cancer are not returning in a timely...

ATS 2022: Hope for IPF stabilisation with new selective PDE4 inhibitor

A preferential phosphodiesterase 4 inhibitor (PDE4B) has shown promise in preventing lung function decline in patients with IPF in an international study including an Australian site. A phase 2 RCT, published in the NEJM and presented at ATS 2022, compared...

A preferential phosphodiesterase 4 inhibitor (PDE4B) has shown promise in preventing lung function decline in patients with IPF in an...